1.Comparative study of STIR image with SE image in diagnosis of the orbital disease.
Soo Nami CHOI ; Ho Kyu LEE ; Dae Chul SUH
Journal of the Korean Radiological Society 1993;29(6):1140-1145
To evaluate the efficacy of STIR (short tau inversio recovery) image in the diagnosis of orbital diseases, we compared the STIR images with conventional SE(spin-echo) images in 17 patients. The fat signal was reliably nulled at inversion time of approximately 160-170 msec in all cases. We analyzed all the cases in the aspects of the detection of lesion and the lesion-to-back ground contrast retrospectively. Regarding lesion, the detection rates of STIR, T1 and T2-weighted images were 89, 88 and 83% respectively. In the aspect of lesion-to-background contrast, the contrast ratios of STIR and T1, T2-weighted image were 87% and 64, 56%, respectively. In conclusion, STIR images were similar to T1-and T2-weighted images in the detection of lesion, but superior in the aspect of lesion-to-background contrast. So the STIR images may be a useful adjunct to conventional SE images for the diagnosis of orbital disease.
Diagnosis*
;
Humans
;
Orbit*
;
Orbital Diseases*
;
Retrospective Studies
2.A Multicenter Prospective Validation Study for the Korean Thyroid Imaging Reporting and Data System in Patients with Thyroid Nodules.
Eun Ju HA ; Won Jin MOON ; Dong Gyu NA ; Young Hen LEE ; Nami CHOI ; Soo Jin KIM ; Jae Kyun KIM
Korean Journal of Radiology 2016;17(5):811-821
OBJECTIVE: To validate a new risk stratification system for thyroid nodules, the Korean Thyroid Imaging Reporting and Data System (K-TIRADS), using a prospective design. MATERIALS AND METHODS: From June 2013 to May 2015, 902 thyroid nodules were enrolled from four institutions. The type and predictive value of ultrasonography (US) predictors were analyzed according to the combination of the solidity and echogenicity of nodules; in addition, we determined malignancy risk and diagnostic performance for each category of K-TIRADS, and compared the efficacy of fine-needle aspiration (FNA) with a three-tier risk categorization system published in 2011. RESULTS: The malignancy risk was significantly higher in solid hypoechoic nodules, as compared to partially cystic or isohyperechoic nodules (each p < 0.001). The presence of any suspicious US features had a significantly higher malignancy risk (73.4%) in solid hypoechoic nodules than in partially cystic or isohyperechoic nodules (4.3-38.5%; p < 0.001). The calculated malignancy risk in K-TIRADS categories 5, 4, 3, and 2 nodules were 73.4, 19.0, 3.5, and 0.0%, respectively; and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for malignancy were 95.5, 58.6, 44.5, 96.9, and 69.5%, respectively, in K-TIRADS categories 4 and 5. The efficacy of FNA for detecting malignancy based on K-TIRADS was increased from 18.6% (101/544) to 22.5% (101/449), as compared with the three-tier risk categorization system (p < 0.001). CONCLUSION: The proposed new risk stratification system based on solidity and echogenicity was useful for risk stratification of thyroid nodules and the decision for FNA. The malignancy risk of K-TIRADS was in agreement with the findings of a previous retrospective study.
Biopsy, Fine-Needle
;
Biopsy, Large-Core Needle
;
Humans
;
Information Systems*
;
Prospective Studies*
;
Retrospective Studies
;
Sensitivity and Specificity
;
Thyroid Gland*
;
Thyroid Neoplasms
;
Thyroid Nodule*
;
Ultrasonography
3.Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions.
Jie SHA ; Jungsik NA ; Jung Ok LEE ; Nami KIM ; Soo Kyung LEE ; Ji Hae KIM ; Ji Wook MOON ; Su Jin KIM ; Hye Jeong LEE ; Jong Il CHOI ; Sun Hwa PARK ; Hyeon Soo KIM
Endocrinology and Metabolism 2014;29(3):363-370
BACKGROUND: The role of small GTPase molecules is poorly understood under high glucose conditions. METHODS: We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. RESULTS: We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. CONCLUSION: These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.
AMP-Activated Protein Kinases
;
Blotting, Western
;
Glucose*
;
GTP Phosphohydrolases
;
Guanine Nucleotide Exchange Factors
;
Metformin
;
Muscle, Skeletal
;
Paxillin
;
Phosphorylation
;
RNA, Messenger
;
Signal Transduction
4.The Korean guideline for breast cancer screening.
Eun Hye LEE ; Boyoung PARK ; Nam Soon KIM ; Hyun Ju SEO ; Kyoung Lan KO ; Jun Won MIN ; Myung Hee SHIN ; Kiheon LEE ; Seeyoun LEE ; Nami CHOI ; Min Hee HUR ; Dong Il KIM ; Min Jung KIM ; Sung Yong KIM ; Sung SUNWOO ; Ji Yeon DANG ; Soo Young KIM ; Yeol KIM ; Won Chul LEE ; Joon JEONG
Journal of the Korean Medical Association 2015;58(5):408-419
Breast cancer is the second most common malignancy among Korean women. The 2002 National Cancer Center screening guideline breast cancer was revised via an evidence-based approach to provide medical personnel with a standard protocol of screening breast cancer. There is moderate-level evidence that biennial screening mammography in asymptomatic women aged 40 to 69 reduces breast cancer mortality, while low-level evidence suggests that screening mammography in women 70 years or older does not reduce breast cancer mortality. The committee concluded that the current evidence is insufficient to assess the benefits and harms of either ultrasonography or clinical breast examination as screening modalities for breast cancer. Future researches about the benefits and harms of the National Breast Cancer Screening Program in Korea are strongly required because the characteristics of breast cancer in Korea are different from those in the West, especially regarding dense breast. In conclusion, the committee recommends biennial screening mammography in asymptomatic women aged 40 to 69 years (grade B recommendation). The committee recommends selective screening mammography in women 70 years or older according to individual risk and preference (grade C recommendation). The committee neither recommends nor opposes ultrasonography and clinical breast examination as screening modalities (grade I recommendation). Symptomatic and high-risk women, however, should be offered complementary measures including ultrasonography and clinical breast examination under clinical supervision.
Breast
;
Breast Neoplasms*
;
Female
;
Humans
;
Korea
;
Mammography
;
Mass Screening*
;
Mortality
;
Organization and Administration
;
Ultrasonography